Cargando…
Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptom...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204942/ https://www.ncbi.nlm.nih.gov/pubmed/37220145 http://dx.doi.org/10.1371/journal.pone.0285728 |
_version_ | 1785045934722252800 |
---|---|
author | Gatti, Arianna Zizzo, Gaetano De Paschale, Massimo Tamburello, Antonio Castelnovo, Laura Faggioli, Paola Maria Clerici, Pierangelo Brando, Bruno Mazzone, Antonino |
author_facet | Gatti, Arianna Zizzo, Gaetano De Paschale, Massimo Tamburello, Antonio Castelnovo, Laura Faggioli, Paola Maria Clerici, Pierangelo Brando, Bruno Mazzone, Antonino |
author_sort | Gatti, Arianna |
collection | PubMed |
description | OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptomatic infection (late convalescents) and fully vaccinated asymptomatic donors (vaccinees). METHODS: Twenty-two convalescents and 13 vaccinees were enrolled. Serum anti-SARS-CoV-2 S1 and N Abs were measured using chemiluminescent immunoassays. QFN was performed following instructions and interferon-gamma (IFN-γ) measured by ELISA. AIM was performed on aliquots of antigen-stimulated samples from QFN tubes. SARS-CoV-2-specific memory CD4(+)CD25(+)CD134(+), CD4(+)CD69(+)CD137(+) and CD8(+)CD69(+)CD137(+) T-cell frequencies were measured by flow cytometry. RESULTS: In convalescents, substantial agreement was observed between QFN and AIM assays. IFN-γ concentrations and AIM(+) (CD69(+)CD137(+)) CD4(+) T-cell frequencies correlated with each other, with Ab levels and AIM(+) CD8(+) T-cell frequencies, whereas AIM(+) (CD25(+)CD134(+)) CD4(+) T-cell frequencies correlated with age. AIM(+) CD4(+) T-cell frequencies increased with time since infection, whereas AIM(+) CD8(+) T-cell expansion was greater after recent reinfection. QFN-reactivity and anti-S1 titers were lower, whereas anti-N titers were higher, and no statistical difference in AIM-reactivity and Ab positivity emerged compared to vaccinees. CONCLUSIONS: Albeit on a limited sample size, we confirm that coordinated, cellular and humoral responses are detectable in convalescents up to 2 years after prior infection. Combining QFN with AIM may enhance detection of naturally acquired memory responses and help stratify virus-exposed individuals in T helper 1-type (T(H)1)-reactive (QFN(pos) AIM(pos) Abs(high)), non-T(H)1-reactive (QFN(neg) AIM(pos) Abs(high/low)), and pauci-reactive (QFN(neg) AIM(neg) Abs(low)). |
format | Online Article Text |
id | pubmed-10204942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102049422023-05-24 Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status Gatti, Arianna Zizzo, Gaetano De Paschale, Massimo Tamburello, Antonio Castelnovo, Laura Faggioli, Paola Maria Clerici, Pierangelo Brando, Bruno Mazzone, Antonino PLoS One Research Article OBJECTIVES: Monitoring of SARS-CoV-2 spread and vaccination strategies have relied on antibody (Ab) status as a correlate of protection. We used QuantiFERON™ (QFN) and Activation-Induced Marker (AIM) assays to measure memory T-cell reactivity in unvaccinated individuals with prior documented symptomatic infection (late convalescents) and fully vaccinated asymptomatic donors (vaccinees). METHODS: Twenty-two convalescents and 13 vaccinees were enrolled. Serum anti-SARS-CoV-2 S1 and N Abs were measured using chemiluminescent immunoassays. QFN was performed following instructions and interferon-gamma (IFN-γ) measured by ELISA. AIM was performed on aliquots of antigen-stimulated samples from QFN tubes. SARS-CoV-2-specific memory CD4(+)CD25(+)CD134(+), CD4(+)CD69(+)CD137(+) and CD8(+)CD69(+)CD137(+) T-cell frequencies were measured by flow cytometry. RESULTS: In convalescents, substantial agreement was observed between QFN and AIM assays. IFN-γ concentrations and AIM(+) (CD69(+)CD137(+)) CD4(+) T-cell frequencies correlated with each other, with Ab levels and AIM(+) CD8(+) T-cell frequencies, whereas AIM(+) (CD25(+)CD134(+)) CD4(+) T-cell frequencies correlated with age. AIM(+) CD4(+) T-cell frequencies increased with time since infection, whereas AIM(+) CD8(+) T-cell expansion was greater after recent reinfection. QFN-reactivity and anti-S1 titers were lower, whereas anti-N titers were higher, and no statistical difference in AIM-reactivity and Ab positivity emerged compared to vaccinees. CONCLUSIONS: Albeit on a limited sample size, we confirm that coordinated, cellular and humoral responses are detectable in convalescents up to 2 years after prior infection. Combining QFN with AIM may enhance detection of naturally acquired memory responses and help stratify virus-exposed individuals in T helper 1-type (T(H)1)-reactive (QFN(pos) AIM(pos) Abs(high)), non-T(H)1-reactive (QFN(neg) AIM(pos) Abs(high/low)), and pauci-reactive (QFN(neg) AIM(neg) Abs(low)). Public Library of Science 2023-05-23 /pmc/articles/PMC10204942/ /pubmed/37220145 http://dx.doi.org/10.1371/journal.pone.0285728 Text en © 2023 Gatti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Gatti, Arianna Zizzo, Gaetano De Paschale, Massimo Tamburello, Antonio Castelnovo, Laura Faggioli, Paola Maria Clerici, Pierangelo Brando, Bruno Mazzone, Antonino Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title | Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title_full | Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title_fullStr | Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title_full_unstemmed | Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title_short | Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status |
title_sort | assessing sars-cov-2-specific t-cell reactivity in late convalescents and vaccinees: comparison and combination of quantiferon and activation-induced marker assays, and relation with antibody status |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204942/ https://www.ncbi.nlm.nih.gov/pubmed/37220145 http://dx.doi.org/10.1371/journal.pone.0285728 |
work_keys_str_mv | AT gattiarianna assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT zizzogaetano assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT depaschalemassimo assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT tamburelloantonio assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT castelnovolaura assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT faggiolipaolamaria assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT clericipierangelo assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT brandobruno assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus AT mazzoneantonino assessingsarscov2specifictcellreactivityinlateconvalescentsandvaccineescomparisonandcombinationofquantiferonandactivationinducedmarkerassaysandrelationwithantibodystatus |